Development and Validation of Bioanalytical Method for Simultaneous Quantification of Anti-Hypertensive Drugs by Using HPLC
Keywords:
Cilnidipine, Metoprolol Succinate, Human plasma, Anti-Hypertensive Drugs, HPLCAbstract
The chromatographic separation was achieved by using eclipse plus C8 (250mm x 4.6mm, 5μm) column by applying isocratic elution using the mobile phase Ⅰ consist of (methanol + acetonitrile 60:40 v/v) and mobile phase Ⅱ consist of (water with 0.01% of diethyl amine) in the ratio 80: 20 (v/v) detection was carried at the 225 nm by employing 1ml/min flow rate. The separation of drugs from the plasma was achieved using protein precipitation technique by acetonitrile. The retention time was found to be 6.573 min and 5.421 min for metoprolol succinate and cilnidipine respectively. The developed method has the linearity range was obtained for RP-UFLC method was 0.5 -16 µg/ml and 1-32 µg/ml for cilnidipine and metoprolol succinate respectively and the regression co-efficient (r 2) is 0.999 for the both drugs. Accuracy & precision is evaluated for the method and found be within the limit and the results were reproducible.
Downloads
References
http://en.wikipedia.org/wiki/Cilnidipine.
Cupp M (2009). "Alternatives for Metoprolol Succinate" (pdf). Pharmacist's Letter / Prescriber's Letter 25 (250302). Retrieved 2012-07-06.
Kyeong-Ryoon Lee, Yoon-Jee Chae, Jong-Hwa Lee, Dae-Duk Kim, Saeho Chong, Chang-Koo Shim & Suk-Jae Chung, Quantification of Cilnidipine in Human Plasma by Liquid Chromatography-Mass Spectrometry, Journal of Liquid Chromatography & Related Technologies, 2012, 35(2), 308-320.
Safhi, Spectrophotometric Method for the Estimation of Cilnidipine in Bulk and Pharmaceutical Dosage forms, Orient. J. Chem., 2013, 29(1), 131-134.
H.S. Leung, X. Yao, F.P. Leung, W.H. Ko, Z.Y. Chen, M. Gollasch, Y. Huang, Br. J. Pharmacol. 147 (2006) 55.
Pantelis S, Zvezdana B, Emad B, Emily K, George LB. Comparative efficacy of two different β-blockers on 24-hour blood pressure control. J Clin Hypertens 2008;10(2):112-8.
Janet BM. Optimal use of β-Blockers in high-risk hypertension: a guide to dosing equivalence. Vasc Health Risk Manage 2010; 6:363–72.
Published
How to Cite
Issue
Section
Copyright (c) 2024 Tropical Journal of Pharmaceutical and Life Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
